Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/7784
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNaci, H-
dc.contributor.authorCylus, J-
dc.contributor.authorVandoros, S-
dc.contributor.authorSato, A-
dc.contributor.authorPerampaladas, K-
dc.date.accessioned2013-12-10T11:58:44Z-
dc.date.available2013-12-10T11:58:44Z-
dc.date.issued2012-
dc.identifier.citationBMJ, 345, e4261, 2012en_US
dc.identifier.issn0959-8138-
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/pubmed/22872693en
dc.identifier.urihttp://bura.brunel.ac.uk/handle/2438/7784-
dc.description© BMJ Publishing Group Ltd 2012en_US
dc.languageeng-
dc.language.isoenen_US
dc.publisherBMJ Publishing Groupen_US
dc.subjectDrug approvalen_US
dc.subjectDrug discoveryen_US
dc.subjectDrug industryen_US
dc.subjectEuropeen_US
dc.subjectEvidence-based medicineen_US
dc.subjectDrug legislationen_US
dc.subjectMarketing of health servicesen_US
dc.subjectTreatment outcomeen_US
dc.subjectUnited Statesen_US
dc.subjectUnited States Food and Drug Administrationen_US
dc.titleRaising the bar for market authorisation of new drugsen_US
dc.typeArticleen_US
dc.identifier.doihttp://dx.doi.org/10.1136/bmj.e4261-
pubs.organisational-data/Brunel-
pubs.organisational-data/Brunel/Brunel Active Staff-
pubs.organisational-data/Brunel/Brunel Active Staff/School of Social Sciences-
Appears in Collections:Economics and Finance
Community Health and Public Health
Dept of Economics and Finance Research Papers

Files in This Item:
File Description SizeFormat 
Fulltext.pdf232.23 kBAdobe PDFView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.